GBS usually begins abruptly with distal, relatively symmetrical onset of paraesthesias and quickly followed by progressive limb weakness. Progression is rapid, with 50% of patients reaching clinical nadir by 2 weeks and more than 90% by 4 weeks. The current diagnostic criteria include <4 weeks of progression to clinical nadir.

2023年10月2日 · Guillain-Barré syndrome (pronounced “ghee-AHN buh-RAY”) is a rare autoimmune condition in which your immune system attacks your peripheral nerves. It leads to symptoms like numbness, tingling and muscle weakness that can progress to paralysis. But with treatment, most people fully recover from the condition.

Guillain-Barré Syndrome (GBS) is a term used to describe acute autoimmune peripheral neuropathy with specific characteristic of ascending symmetrical flaccid paralysis of limbs accompanied with hyporeflexia or areflexia.

Objective: To present an overview of reported drug-associated Guillain-Barré syndrome (GBS) and current management of the disease. Data sources: Case reports and reviews of drug-associated GBS published in the English-language literature from 1982 through 1994 were retrieved from MEDLINE.

Compare risks and benefits of common medications used for Guillain-Barre Syndrome. Find the most popular drugs, view ratings and user reviews.

2019年9月20日 · Guillain–Barré syndrome (GBS) is a rare, but potentially fatal, immune-mediated disease of the peripheral nerves and nerve roots that is usually triggered by...

Background: Guillain-Barré Syndrome (GBS) is currently considered the most common global cause of acute flaccid paralysis. Currently, standard therapy for Guillain-Barré Syndrome includes intravenous immunoglobulin or plasma exchange. Despite medical advances regarding these treatments, many treated patients do not reach full recovery.

Intravenous immunoglobulins (IVIg) and plasma exchange (PE) are two established evidence-based immunomodulatory treatments for GBS, but a significant proportion of GBS patients fails to respond adequately to either therapy. This emphasizes an urgent need for …

Guillain-Barré syndrome (GBS) can be described as a collection of clinical syndromes that manifests as an acute inflammatory polyradiculoneuropathy with resultant...

2021年7月14日 · Guillain-Barré syndrome (GBS) is an acute, ascending, predominantly motor paralysis with respiratory failure. Albuminocytologic dissociation in the cerebrospinal fluid is a laboratory biomarker to distinguish this disorder from other neuropathies and from...